Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07070401 · ClinicalTrials.gov registry record · NA

The Use of AR / VR in Patients Presenting to the ED With Renal Colic

A NA study of Renal Colic and Kidney Stones, Urolithiasis, Hypocitraturia, sponsored by Community Medical Center, Toms River, NJ.

Recruiting
Registry status
NA
Development phase
92
Enrollment target
1
Study location

NCT07070401 is a NA study of Renal Colic and Kidney Stones, Urolithiasis, Hypocitraturia that is actively recruiting participants, run by Community Medical Center, Toms River, NJ. The registered enrollment target is 92 participants, above the 69-participant average among 3 other Renal Colic trials with a reported enrollment target (33% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07070401, a NA study of Renal Colic and Kidney Stones, Urolithiasis, Hypocitraturia, is actively recruiting participants, sponsored by Community Medical Center, Toms River, NJ.

RECRUITING
Registry status
NA
Development phase
92 participants
Enrollment target
1
Study location

Study Summary

Utilization of VR / AR Calming as an adjunct to pharmacologic pain management for Renal Colic in Emergency Department Patients

Interventions

  • DEVICE Commercial AR/VR Headset with Calming App
  • OTHER Pharmacologic Standard of Care Alone

Study Locations (1)

New Jersey

  • Rutgers Robert Wood Johnson Barnabas Health Community Medical Center - Toms River

Trial Details

FieldValue
Enrollment Target 92 participants
Start Date 2025-04-01
Est. Completion 2026-03-31
Phase NA

What the Registry Record Tells You About NCT07070401

The ClinicalTrials.gov registry entry for NCT07070401 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 92 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 69-participant average among 3 other Renal Colic trials with a reported enrollment target (33% higher). The listed sponsor is Community Medical Center, Toms River, NJ, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Renal Colic appearing as the primary indexed condition, and to 2 interventions - of which Commercial AR/VR Headset with Calming App is the first listed.

NCT07070401 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.

Frequently Asked Questions

What is clinical trial NCT07070401 about?

NCT07070401 is a clinical study titled "The Use of AR / VR in Patients Presenting to the ED With Renal Colic". Utilization of VR / AR Calming as an adjunct to pharmacologic pain management for Renal Colic in Emergency Department Patients

What is the current status of trial NCT07070401?

This trial is currently recruiting. It is a NA study. The enrollment target is 92 participants. The study started on 2025-04-01. Estimated completion is 2026-03-31.

What conditions does trial NCT07070401 study?

This clinical trial studies the following conditions: Renal Colic, Kidney Stones, Urolithiasis, Hypocitraturia.

What interventions are being tested in trial NCT07070401?

The interventions under investigation include: Commercial AR/VR Headset with Calming App (DEVICE), Pharmacologic Standard of Care Alone (OTHER).

Who is sponsoring clinical trial NCT07070401?

This trial is sponsored by Community Medical Center, Toms River, NJ, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07070401 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Renal Colic

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.